Antıbody to Certolızumab Pegol ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Certolizumab Pegol (Cimzia®) in serum and plasma.

The solid phase (MTP) is coated by the drug Certolizumab Pegol. Due to the assay design this test measures the free antibodies which are not bound to Certolizumab Pegol. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).

Reference: IG-BB109

Barcode: 8682754930264

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

CoA BB109-204

Cimzia® is a trademark of  UCB.

 

Required Volume (µL) 50
Incubation Time (min) 135
Sample Serum, Plasma
Package Size 96
Results in Qualitative & Quantitative (ng/mL)
Shelf Life (years) 2